-
October 20, 2026
Law firm Polsinelli PC has asked a Tennessee federal judge to sanction a medical device company for advancing what it says were "knowingly false and materially incomplete" positions in a suit accusing the firm of pursuing bad faith patent infringement claims on behalf of a client.
-
October 20, 2026
Britain's antitrust regulator invited comments Tuesday on whether local medical device maker Intersurgical's proposed $530 million acquisition of two businesses could harm competition in U.K. markets.
-
October 20, 2026
Freshfields LLP has hired a former Gibson Dunn & Crutcher LLP lawyer who focuses his practice on identifying, assessing and mitigating risks associated with U.S. Food and Drug Administration oversight, the firm recently announced.
-
October 19, 2026
California and 23andMe's corporate successor have reached a $6 million settlement that, if approved, would resolve the state's allegations that the genetic testing company failed to protect customers' sensitive information in a 2023 data breach, as well as the state's objection to 23andMe's sale of genetic data during bankruptcy proceedings.
-
October 19, 2026
Biotechnology company TriGemX Bio on Monday unveiled plans to go public by merging with special purpose acquisition company TCGX Acquisition Corp. in a deal built by five law firms that creates a combined company with a $600 million post-transaction equity value.
-
October 19, 2026
The Fifth Circuit has overturned the class status of investors accusing Cassava Sciences Inc. of making misleading statements about clinical trial results for a potential Alzheimer's drug, saying that a lower court judge did not properly consider the company's arguments that its stock price was impacted by the "meme stock" craze.
-
October 19, 2026
The Delaware Chancery Court last week blocked Cloudflare Inc. from completing a restructuring meant to preserve its founders' voting control, while Tower Semiconductor Ltd. accused Intel Corp. of backing out of a semiconductor manufacturing agreement and social media company Triller Group Inc. challenged its removal from Nasdaq.
-
October 19, 2026
Mylan can use deposition testimony from one current and one former executive in next year's price-fixing trial, a Connecticut federal judge ruled Friday, but state attorneys general can bring up the company "pulling the strings" in the witnesses' decision to testify after originally invoking the Fifth Amendment.
-
October 19, 2026
The U.S. Department of Justice said it's asking the Fifth Circuit to review a Texas federal judge's decision to grant a new trial for a former NFL player convicted in a $328 million Medicare billing scheme.
-
October 19, 2026
Germany's Merck said Monday it has agreed to acquire U.K. biotechnology company Silence Therapeutics PLC at a $1.3 billion equity value, with Allen Overy Shearman Sterling advising Merck and Cooley LLP representing Silence Therapeutics.
-
October 19, 2026
The Federal Circuit will not reinstate a jury's $59.4 million trade secret theft verdict against EOFlow Co. Ltd., rejecting insulin product developer Insulet Corp.'s request for rehearing of a panel decision overturning the award.
-
October 16, 2026
The Second Circuit on Friday denied a bid by Tylenol maker Kenvue and several retailers to reconsider its ruling that a district court improperly excluded expert testimony for plaintiffs who claim prenatal exposure to the over-the-counter pain reliever causes autism and ADHD.
-
October 16, 2026
Lawyers representing clients against the federal government spoke Friday about the challenges and rewards of such litigation in the Trump era, with plaintiff-side powerhouse Elizabeth Cabraser pointing to the potential for massive impact, including one case in which she successfully got more than a billion dollars in grant funding reinstated.
-
October 16, 2026
The co-founder of a company that sells medical devices told a Colorado state court Thursday that the company lowered the percentage he is owed of $7.7 million in outstanding receivables from a client without approval.
-
October 16, 2026
Third-quarter capital markets activity in the U.S. proved to be robust with a solid string of initial public offerings, but capital markets attorneys say it did not fully meet expectations due to delays of notable IPOs caused by market uncertainty.
-
October 16, 2026
The Federal Trade Commission has requested additional information about MiMedx Group Inc.'s planned $350 million purchase of Sanara MedTech Inc., a company that develops and commercializes products for use during surgery.
-
October 16, 2026
Blood clot-focused biotechnology firm City Therapeutics began trading publicly Friday after raising $200 million in its upsized initial public offering steered by Goodwin Procter LLP and Cooley LLP, joining a wave of biotechnology public listings over the past few weeks.
-
October 16, 2026
U.S. Supreme Court Justice Neil Gorsuch is concerned that a ruling instructing trial courts to defer to the U.S. Sentencing Commission's interpretation of federal sentencing guidelines could blow a "pretty big hole" in the court's recent rejection of deference doctrines. His colleagues, however, don't appear as perturbed.
-
October 16, 2026
A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug price-fixing and market allocation, setting aside $280 million as restitution.
-
October 16, 2026
A California state judge has rejected a cannabis genetics company's bid for an injunction against a former business partner in a contract dispute, saying the contract's self-contradictory provisions make it unclear that the company is entitled to retrieve its cannabis strains.
-
October 16, 2026
EpicentRx's former corporate secretary urged the Delaware Chancery Court on Friday to impose a partial default judgment against the biotechnology firm and appoint a receiver, arguing it has continued to ignore advancement and contempt orders. Meanwhile, the company countered that those remedies would be disproportionate to what it says is ultimately a dispute over unpaid money.
-
October 16, 2026
In this week's Taxation With Representation, Penske Automotive Group Inc. agrees to be taken private by Motown Acquisition Corp., a GTCR-led group of private investment firms acquires software firm CCC Intelligent Solutions Holdings Inc. and a Steris PLC subsidiary buys specialty surgical products business Xodus Medical Inc.
-
October 16, 2026
The top investigative priorities of a potentially Democratic-controlled Congress are coming into sharper focus with the midterms weeks away and could impact an array of companies and individuals in technology, finance and energy, experts say.
-
October 16, 2026
Mayer Brown LLP has bolstered its life sciences capabilities with two former Sheppard partners, including that firm's former U.S. Food and Drug Administration practice leader.
-
October 16, 2026
ASX-listed Mayne Pharma announced on Friday another settlement related to its oestradiol vaginal insert Imvexxy, with medicines maker Teva Pharmaceuticals USA Inc. agreeing not to enter the U.S. market with a generic version until 2032.